Seed Biotechnology Companies

NeuroLife technology is designed to support applications across rehabilitation, neuromuscular analytics and future neuro-enabled solutions.

VIAN Therapeutics is an ophthalmology pharma startup combating microvascular retinal diseases (AMD and DME) with a simple eyedrop.

Yutide Therapeutics is an animal health biotechnology company that develops therapeutics and antimicrobial peptides for companion animals.

SINGLE TECHNOLOGIES develops a new type of (3-D) DNA sequencing system to improve Life.

TRIMTECH Therapeutics treats inflammatory and persistent CNS conditions by focusing on the elimination of harmful proteins.

ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.

Avivo Biomedical operates as a preclinical-stage company.

Vienna Textile Lab fabricates organic colors made from naturally occurring bacteria.

Current Foods creates plant-based alternatives for people's seafood favorites.

Tolerance Bio is a biopharmaceutical company focused on manipulating immune tolerance via the thymus.

precision-immunology techbio

ChemT Biotechnology is an AI platform that researches and develops molecules for biotechnology manufacturers.

OCI develops therapies for leukaemia based on CAR–T.

Hyfé turns food waste into chemicals that maximize profits for food processors while allowing the world to make products without petroleum.

Inside Therapeutics offers microfluidic-based systems for nanoparticle manufacturing, focusing on LNP-RNA vaccine development and oncology.

Cambrium is engineering biology to create high-performance proteins.

Nexsis Biosciences is a biotechnology company.

Houdini Bio develops computational synthetic biology tools to redesign DNA constructs for improved genetic medicines.

Oria Bioscience is a pure biotechnology company that produces intact organelles for therapeutic opportunities.

Myriad Optics is a new bacterial contamination detection solutions for the food industry.

Anoat Therapeutics develops an innovative, disease-modifying approach in Cystic Fibrosis.

ŌGI Bio is a Biotechnology Research company.

Founded in 2022, we are a spin-out from Singapore-MIT Alliance for Research and Technology (SMART) and NTU Lee.

Ability Biologics dedicated to developing the most potent and selective antibody therapeutics for areas of great unmet need..

NXI Therapeutics develops next-gen immunosuppressive drugs for autoimmune diseases and organ transplantation.